Upstart shares are moving higher in Tuesday's after-hours session after the company announces plans to apply for a national bank charter.

Ramsey then shifted the focus to borrowing trends he says have become common among people entering adulthood over the past two decades. "What is happening with Gen Z and millennia ...

Tesla is advertising several products across social media platforms that aren't X. Here's the companies and products.

Markwayne Mullin made several stock transaction in February 2026, before he was nominated to lead the Department of Homeland Security.

L3Harris Technologies (NYSE:LHX) has outperformed the market over the past 20 years by 2.31% on an annualized basis producing an average annual return of 10.88%. Currently, L3Harris Technologies has a ...

Vanguard Information Tech ETF (NYSE:VGT) has outperformed the market over the past 5 years by 3.86% on an annualized basis producing an average annual return of 15.16%. Currently, Vanguard Information ...

Block (NYSE:XYZ) has outperformed the market over the past 10 years by 5.71% on an annualized basis producing an average annual return of 18.56%. Currently, Block has a market capitalization of $39.80 ...

The Q4 earnings report for Pangaea Logistics Solns (NASDAQ:PANL) was released on Tuesday, March 10, 2026 at 05:38 PM. Here's what investors need to know about the latest announcem ...

WTI crude collapsed nearly 30% since its Sunday night's peak, yet U.S. gasoline and diesel prices keep rising. Refiners and fuel distributors may be the biggest beneficiaries of the widening crack ...

The Q4 earnings report for Natures Sunshine Products (NASDAQ:NATR) was released on Tuesday, March 10, 2026 at 04:05 PM. Here's what investors need to know about the latest announc ...

Ur-Energy (AMEX:URG) reported its Q4 earnings results on Tuesday, March 10, 2026 at 05:30 PM. Here's what investors need to know about the announcement. Earnings. Ur-Energy missed ...

The clinical-stage biotech company, which specializes in cellular therapies for rare pediatric and aging-related conditions, secured the funding to advance its lead candidate, laromestrocel. The ...